As of 2025-08-09, the Intrinsic Value of Biovaxys Technology Corp (BIOV.CN) is -0.09 CAD. This BIOV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Biovaxys Technology Corp is -572.26%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Biovaxys Technology Corp (BIOV.CN) is overvalued by 572.26%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.09 - -0.09 | -0.09 | -572.26% |
| P/E | (0.00) - 0.01 | 0.00 | -78.7% |
| DDM - Stable | (0.42) - 3.49 | 1.54 | 7593.4% |
| DDM - Multi | (0.30) - 1.92 | (0.70) | -3580.7% |
| Market Cap (mil) | 5.87 |
| Beta | -0.29 |
| Outstanding shares (mil) | 293.43 |
| Enterprise Value (mil) | 5.78 |
| Market risk premium | 5.10% |
| Cost of Equity | 5.35% |
| Cost of Debt | 5.00% |
| WACC | 5.33% |